Summary
The effects of subclinical vitamin D deficiency and vitamin D supplementation on oral glucose tolerance and secretion of pancreatic hormones were studied in 10 diphenyl-hydantoin-treated epileptic patients and 15 geriatric patients. Their mean serum concentrations of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 decreased markedly, but returned to normal within 2 weeks of oral supplementation with 25-hydroxyvitamin D3. The serum concentration of ionized calcium was within the normal range before treatment, and remained unchanged. Serum parathyroid hormone was increased during vitamin D deficiency, but decreased significantly (p < 0.05) afterwards. In vitamin D-deficient epileptic and geriatric patients, the 2- and 3-h insulin levels after glucose ingestion were increased when compared with control values, and glucagon secretion was not suppressed by glucose. Oral glucose tolerance of both groups of patients did not change after 25-hydroxyvitamin D3 supplementation. Insulin secretion remained unchanged in geriatric patients, but was reduced to normal values in epileptic patients. Glucagon suppressibility by glucose was partly restored after vitamin D supplementation in epileptic patients but not in geriatric patients. In contrast to that observed in severely vitamin D-deficient rats or rabbits, correction of subclinical vitamin D deficiency failed to enhance insulin secretion or to improve glucose tolerance in man.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Fraser DR (1980) Regulation of the metabolism of vitamin D. Physiol Rev 60: 551–613
Marx SJ, Liberman UA, Eil C (1983) Calciferols: actions and deficiencies in action. Vitam Horm 40: 235–308
Clark SA, Stumpf NE, Sar M, DeLuca HF, Tanaka Y (1980) Target cells for 1,25-dihydroxyvitamin D3 in the pancreas. Cell Tissue Res 209: 515–520
Roth J, Bonner-Weir S, Norman AW, Orci L (1982) Immunocytochemistry of vitamin D-binding protein in chick pancreas: exclusive localization in B-cells. Endocrinology 110: 2216–2218
Clark SA, Stumpf WE, Sar M (1981) Effect of 1,25-dihydroxyvitamin D3 on insulin secretion. Diabetes 30: 382–386
Norman AW, Frankel BJ, Heldt AM, Grodsky GM (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209: 823–825
Nyomba BL, Bouillon R, De Moor P (1984) Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. Endocrinology 115: 191–197
Kadowaki S, Norman AW (1984) Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest 73: 759–766
Ishida H, Seino Y, Seino S, Tsuda K, Takemura J, Nishi S, Ishizuka S, Imura H (1983) Effect of 1,25-dihydroxyvitamin D3 on pancreatic B and D cell function. Life Sci 33: 1779–1786
Felig P, Sherwin RS, Soman V, Wahren J, Hendler R, Sacca L, Eigler N, Goldberg D, Walesky M (1979) Hormonal interactions in the regulation of blood glucose. Rec Progr Horm Res 35: 501–532
Bouillon R, Van Kerkhove P, De Moor P (1976) Measurement of 25-hydroxyvitamin D3 in serum. Clin Chem 22: 364–368
Bouillon R, Van Baelen H, De Moor P (1977) The measurement of vitamin D-binding protein in human serum. J Clin Endocrinol Metab 45: 225–231
Bouillon R, De Moor P (1977) Parathyroid hormone secretion in primary hyperparathyroidism. J Clin Endocrinol Metab 45: 261–269
Bouillon R, De Moor P, Baggiolini EG, Uskokovic MR (1980) A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin Chem 26: 562–567
Bouillon R, Van Assche FA, Van Baelen H, Heyns H, De Moor P (1981) Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest 67: 589–596
Albano JDM, Ekins RP, Maritz G, Turner RC (1972) A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol 70: 487–509
Snedecor GW, Cochran WG (1967) Statistical methods. The Iowa State University Press, Ames, Iowa, p 301
Fariss BL, Lutcher CL (1971) Diphenylhydantoin-induced hyperglycemia and impaired insulin release. Effect of dosage. Diabetes 20: 177–181
Kawashima H, Castro A (1981) Effect of 1α-hydroxyvitamin D3 on the glucose and calcium metabolism in genetic obese mice. Res Commun Chem Pathol Pharmacol 33:155–161
Chertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A, DeLuca HF (1983) Cellular mechanism of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 113: 1511–1518
Frankel BJ, Schlin J, Taljedal B (1984) Vitamin D3 stimulates45Ca2+ uptake by mouse islets in vitro. Diabetes 33: 154A
Pek S (1977) Glucagon and diabetes. Clin Endocrinol Metab 6: 333–344
Unger RH, Dobbs RE, Orci L (1978) Insulin, glucagon, and somatostatin secretion in the regulation of metabolism. Ann Rev Physiol 40: 307–343
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nyomba, B.L., Auwerx, J., Bormans, V. et al. Pancreatic secretion in man with subclinical vitamin D deficiency. Diabetologia 29, 34–38 (1986). https://doi.org/10.1007/BF02427278
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02427278